Toxic effects of colloids in the intensive care unit.
Colloid fluid solutions are frequently used as plasma volume expanders in the critically ill. As a group, these nonblood volume replacement solutions have in common a number of potential adverse effects. Intravascular volume overload, dilutional coagulopathy, extravascular extravasation across leaky capillary membranes, and anaphylactoid reactions may all occur with administration of any colloid. In addition, individual agents have unique toxic effects. Renal dysfunction has been associated with dextran 40, myocardial depression with albumin, hypotension with purified plasma protein, and hyperamylasemia with hetastarch. Because no ideal colloidal solution exists, knowledge of type, severity, and clinical significance of adverse effects is important in determining the appropriate plasma volume expander and monitoring its effects.
Nearman
H S
HS
University Hospitals of Cleveland, Ohio.
Herman
M L
ML
D000418:Albumins / Q000009:adverse effects; D001802:Blood Substitutes / Q000009:adverse effects; D003102:Colloids / Q000009:adverse effects*; D003422:Critical Care; D003911:Dextrans / Q000009:adverse effects; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects; D007362:Intensive Care Units; D010952:Plasma Substitutes / Q000009:adverse effects*
D000418:Albumins; D001802:Blood Substitutes; D003102:Colloids; D003911:Dextrans; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes